Treatment and Survival for Patients with Localized Primary Ocular Adnexal Extranodal Marginal Zone Lymphoma

Overview

Journal Leukemia

Specialties Hematology
Oncology

Date 2024 Mar 20

PMID 38503872

Authors

Lin-Rui Gao

Xin Li

Xinyue Wang

Yuanzheng Liang

Yunpeng Wu

Xiao-Li Feng

Wei Rao

Xin Liu

Yong-Wen Song

Hui Fang

Bo Chen

Jing Jin

Yue-Ping Liu

Hao Jing

Yuan Tang

Ning-Ning Lu

Shu-Lian Wang

Ye-Xiong Li

Liang Wang

Shu-Nan Qi

Affiliations

Soon will be listed here.

References

Moslehi R, Devesa S, Schairer C, Fraumeni Jr J . Rapidly increasing incidence of ocular non-hodgkin lymphoma. J Natl Cancer Inst. 2006; 98(13):936-9. DOI: 10.1093/jnci/djj248. View

Wu Y, Liu X, Imber B, Zhong Q, Yang Y, Wu T . Influence of age on long-term net survival benefit for early-stage MALT lymphomas treated with radiotherapy: A SEER database analysis (2000-2015). Radiother Oncol. 2022; 173:179-187. DOI: 10.1016/j.radonc.2022.05.034. View

Olszewski A, Desai A . Radiation therapy administration and survival in stage I/II extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. Int J Radiat Oncol Biol Phys. 2014; 88(3):642-9. DOI: 10.1016/j.ijrobp.2013.11.225. View

Holm F, Mikkelsen L, Kamper P, Rasmussen P, Larsen T, Sjo L . Ocular adnexal lymphoma in Denmark: a nationwide study of 387 cases from 1980 to 2017. Br J Ophthalmol. 2020; 105(7):914-920. DOI: 10.1136/bjophthalmol-2019-315637. View

Zucca E, Arcaini L, Buske C, Johnson P, Ponzoni M, Raderer M . Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2020; 31(1):17-29. DOI: 10.1016/j.annonc.2019.10.010. View

Teckie S, Qi S, Chelius M, Lovie S, Hsu M, Noy A . Long-term outcome of 487 patients with early-stage extra-nodal marginal zone lymphoma. Ann Oncol. 2017; 28(5):1064-1069. PMC: 5834123. DOI: 10.1093/annonc/mdx025. View

Olszewski A, Castillo J . Survival of patients with marginal zone lymphoma: analysis of the Surveillance, Epidemiology, and End Results database. Cancer. 2012; 119(3):629-38. DOI: 10.1002/cncr.27773. View

Saul E, Alderuccio J, Reis I, Zhao W, Iyer S, Rodriguez G . Long-term outcomes of patients with conjunctival extranodal marginal zone lymphoma. Am J Hematol. 2022; 98(1):148-158. DOI: 10.1002/ajh.26591. View

Masuda Y, Takeuchi K, Kodama T, Fujisaki T, Imaizumi Y, Otsuka E . Treatment-associated outcomes of patients with primary ocular adnexal MALT lymphoma after accurate diagnosis. Int J Clin Oncol. 2019; 24(12):1620-1628. DOI: 10.1007/s10147-019-01481-3. View

10.

Desai A, Joag M, Lekakis L, Chapman J, Vega F, Tibshirani R . Long-term course of patients with primary ocular adnexal MALT lymphoma: a large single-institution cohort study. Blood. 2016; 129(3):324-332. DOI: 10.1182/blood-2016-05-714584. View

11.

Hindso T, Esmaeli B, Holm F, Mikkelsen L, Rasmussen P, Coupland S . International multicentre retrospective cohort study of ocular adnexal marginal zone B-cell lymphoma. Br J Ophthalmol. 2019; 104(3):357-362. DOI: 10.1136/bjophthalmol-2019-314008. View

12.

Lee J, Yoon J, Kim J, Koom W, Cho J, Suh C . Long-term outcome, relapse patterns, and toxicity after radiotherapy for orbital mucosa-associated lymphoid tissue lymphoma: implications for radiotherapy optimization. Jpn J Clin Oncol. 2019; 49(7):664-670. DOI: 10.1093/jjco/hyz044. View

13.

Hoskin P, Popova B, Schofield O, Brammer C, Robinson M, Brunt A . 4 Gy versus 24 Gy radiotherapy for follicular and marginal zone lymphoma (FoRT): long-term follow-up of a multicentre, randomised, phase 3, non-inferiority trial. Lancet Oncol. 2021; 22(3):332-340. DOI: 10.1016/S1470-2045(20)30686-0. View

14.

Yang X, Wang R, Yuan X, Yao S, Wang C, Cheng J . Ultra-low-dose radiotherapy in the treatment of ocular adnexal lymphoma: a prospective study. Radiat Oncol. 2022; 17(1):208. PMC: 9764465. DOI: 10.1186/s13014-022-02180-6. View